Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lori A. Wood"'
Autor:
Margaret Sheridan, Bruce Colwell, Nathan W. D. Lamond, Robyn Macfarlane, Daniel Rayson, Stephanie Snow, Lori A. Wood, Ravi Ramjeesingh
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3149-3159 (2023)
(1) Background: Cancer is the leading cause of death in Canada, with significant resource limitation impacting the delivery of cancer care nationwide. The onset of the COVID-19 pandemic forced additional resource restriction and diversion, further im
Externí odkaz:
https://doaj.org/article/82bc1cd275b64db0ba97d61752f45889
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1808-1812 (2022)
A standard curative intent approach of chemotherapy treatment for metastatic testicular cancer has been well established. However, there is little guidance for patients undergoing hemodialysis (HD) who require chemotherapy for this disease. Thus, we
Externí odkaz:
https://doaj.org/article/47e16e6cc8394756b6105f7bad2f34d4
Autor:
Eric K. Nguyen, MD, Aly Khan A. Lalani, MD, Sunita Ghosh, PhD, PStat, Naveen S. Basappa, MD, Anil Kapoor, MD, Aaron R. Hansen, MD, Christian Kollmannsberger, MD, Daniel Heng, MD, MPH, Lori A. Wood, MD, MSc, Vincent Castonguay, MD, Denis Soulières, MD, MSc, Eric Winquist, MD, MSc, Christina Canil, MD, Jeffrey Graham, MD, Georg A. Bjarnason, MD, Rodney H. Breau, MD, MSc, Frédéric Pouliot, MD, PhD, Anand Swaminath, MD, MSc
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100899- (2022)
Purpose: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this
Externí odkaz:
https://doaj.org/article/43f035c672774db193ffcf1e0e1b7f1a
Autor:
Matthew S. Ernst, Vishal Navani, J. Connor Wells, Frede Donskov, Naveen Basappa, Chris Labaki, Sumanta K. Pal, Luis Meza, Lori A. Wood, D. Scott Ernst, Bernadett Szabados, Rana R. McKay, Francis Parnis, Cristina Suarez, Takeshi Yuasa, Aly-Khan Lalani, Ajjai Alva, Georg A. Bjarnason, Toni K. Choueiri, Daniel Y.C. Heng
Publikováno v:
European Urology. 83:e166-e167
Publikováno v:
Can Urol Assoc J
Introduction: Cancer registries are the mainstay for Canadian population-based cancer statistics. Data are collected in provincial and territorial registries, including the Nova Scotia Cancer Registry (NSCR). The goal of this study was to determine t
Autor:
Jeffrey Graham, John Connor Wells, Shaan Dudani, Chun L. Gan, Frede Donskov, Jae-lyun Lee, Christian K. Kollmannsberger, Luis Meza, Benoit Beuselinck, Aaron Hansen, Scott A. North, Georg A. Bjarnason, Nicolas Sayegh, Ravindran Kanesvaran, Lori A. Wood, Sebastien J. Hotte, Rana R. McKay, Toni K. Choueiri, Daniel Y.C. Heng
Publikováno v:
Graham, J, Wells, J C, Dudani, S, Gan, C L, Donskov, F, Lee, J L, Kollmannsberger, C K, Meza, L, Beuselinck, B, Hansen, A, North, S A, Bjarnason, G A, Sayegh, N, Kanesvaran, R, Wood, L A, Hotte, S J, McKay, R R, Choueiri, T K & Heng, D Y C 2022, ' Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy ', European Journal of Cancer, vol. 171, pp. 124-132 . https://doi.org/10.1016/j.ejca.2022.05.002
Background: Immune checkpoint inhibitors (ICI) have demonstrated impressive activity in metastatic clear-cell renal cell carcinoma (ccRCC) and have become standard treatment options for patients with advanced disease. Data supporting the effectivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf7f7a690f1adb77e00dfe925d16923
https://pure.au.dk/portal/da/publications/outcomes-of-patients-with-advanced-nonclear-cell-renal-cell-carcinoma-treated-with-firstline-immune-checkpoint-inhibitor-therapy(815bec8e-eed6-4416-8d49-526e10c3220b).html
https://pure.au.dk/portal/da/publications/outcomes-of-patients-with-advanced-nonclear-cell-renal-cell-carcinoma-treated-with-firstline-immune-checkpoint-inhibitor-therapy(815bec8e-eed6-4416-8d49-526e10c3220b).html
Autor:
Vishal Navani, Matthew Ernst, J. Connor Wells, Takeshi Yuasa, Kosuke Takemura, Frede Donskov, Naveen S. Basappa, Andrew Schmidt, Sumanta K. Pal, Luis Meza, Lori A. Wood, D. Scott Ernst, Bernadett Szabados, Thomas Powles, Rana R. McKay, Andrew Weickhardt, Cristina Suarez, Anil Kapoor, Jae Lyun Lee, Toni K. Choueiri, Daniel Y. C. Heng
Publikováno v:
Scientia
Navani, V, Ernst, M, Wells, J C, Yuasa, T, Takemura, K, Donskov, F, Basappa, N S, Schmidt, A, Pal, S K, Meza, L, Wood, L A, Ernst, D S, Szabados, B, Powles, T, McKay, R R, Weickhardt, A, Suarez, C, Kapoor, A, Lee, J L, Choueiri, T K & Heng, D Y C 2022, ' Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients with Metastatic Renal Cell Carcinoma ', JAMA network open, vol. 5, no. 6, pp. E2216379 . https://doi.org/10.1001/jamanetworkopen.2022.16379
Navani, V, Ernst, M, Wells, J C, Yuasa, T, Takemura, K, Donskov, F, Basappa, N S, Schmidt, A, Pal, S K, Meza, L, Wood, L A, Ernst, D S, Szabados, B, Powles, T, McKay, R R, Weickhardt, A, Suarez, C, Kapoor, A, Lee, J L, Choueiri, T K & Heng, D Y C 2022, ' Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients with Metastatic Renal Cell Carcinoma ', JAMA network open, vol. 5, no. 6, pp. E2216379 . https://doi.org/10.1001/jamanetworkopen.2022.16379
Combination Therapies; Metastatic Renal Cell Carcinoma Terapias combinadas; Carcinoma metastásico de células renales Teràpies combinades; Carcinoma metastàtic de cèl·lules renals Importance The association between treatment with first-line immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382f563828aaa4d234103df39b0657ec
https://hdl.handle.net/11351/8086
https://hdl.handle.net/11351/8086
Publikováno v:
BMJ Case Reports. 15:e251661
We report a case of a man in his early 70s with a known history of prostate adenocarcinoma who presented with an undiagnosed skin lesion on his right lower lateral neck 6 years after his metastatic cancer diagnosis. The painless lesion was pink, lobu
Autor:
Eric K. Nguyen, Aly Khan A. Lalani, Sunita Ghosh, Naveen S. Basappa, Anil Kapoor, Aaron R. Hansen, Christian Kollmannsberger, Daniel Heng, Lori A. Wood, Vincent Castonguay, Denis Soulières, Eric Winquist, Christina Canil, Jeffrey Graham, Georg A. Bjarnason, Rodney H. Breau, Frédéric Pouliot, Anand Swaminath
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100899-(2022)
Purpose: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this
Autor:
Camilla, Tajzler, Simon, Tanguay, Ranjeeta, Mallick, Beau, Ahrens, Tina Luu, Ly, Rodney H, Breau, Naveen S, Basappa, Anil, Kapoor, Daniel Y C, Heng, Frédéric, Pouliot, Antonio, Finelli, Luke T, Lavallée, Alan I, So, Darrel E, Drachenberg, Denis, Soulières, Georg A, Bjarnason, Patrick O, Richard, Ranjena, Maloni, Nicholas E, Power, Michael, Haan, Lori A, Wood
Publikováno v:
Can Urol Assoc J
INTRODUCTION: The Canadian Kidney Cancer information system (CKCis) has prospectively collected data on patients with renal tumors since January 1, 2011 from 16 sites within 14 academic centers in six provinces. Canadian kidney cancer experts have us